VEGFA and neoplasm: For instance, intraperitoneal administration of 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) nanoliposomes enriched in miR-192 leads to reduced angiogenesis and tumor regression compared to control and anti-VEGF antibody treatments [248].